Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
THRV-1268 by Thryv Therapeutics for Atrial Fibrillation: Likelihood of Approval
THRV-1268 is under clinical development by Thryv Therapeutics and currently in Phase I for Atrial Fibrillation. According to GlobalData, Phase...
Data Insights
THRV-1268 by Thryv Therapeutics for Diastolic Heart Failure (HFpEF): Likelihood of Approval
THRV-1268 is under clinical development by Thryv Therapeutics and currently in Phase I for Diastolic Heart Failure (HFpEF). According to...